A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors - Concepedia

Concepedia

Publication | Open Access

A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors

DOI Full Paper Access

100

Citations

13

References

2016

Year

Toshio Shimizu, Kazuya Fukuoka, Masayuki Takeda, T. Iwasa, Takeshi Yoshida, Joanna Horobin, Mitchell Keegan, Lou Vaickus, Ajit Chavan, Mahesh V. Padval,

Cancer Chemotherapy and Pharmacology

References

	Year	Citations

Page 1